<DOC>
	<DOCNO>NCT01806896</DOCNO>
	<brief_summary>This study evaluate Safety , Tolerability Brain Function 2 dose PF-0254920 Subjects Early Huntington 's Disease .</brief_summary>
	<brief_title>Study Evaluating The Safety , Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Huntington Disease</mesh_term>
	<criteria>Must diagnosis Huntington 's Disease CAG repeat expansion equal great 39 Unified Huntington Disease Rating Scale ( UHDRS ) Total Motor Score equal great 5 less 60 UHDRS Total Functional Capacity equal great 9 Subjects evidence history severe acute chronic medical condition laboratory abnormality , significant neurological disorder HD . Treatment antipsychotic medication within 5 week enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>